Lake Street Capital Cuts Ekso Bionics (NASDAQ:EKSO) Price Target to $1.00

Ekso Bionics (NASDAQ:EKSO) had its target price cut by equities researchers at Lake Street Capital from $2.00 to $1.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Lake Street Capital’s target price suggests a potential upside of 110.00% from the stock’s previous close.

EKSO has been the topic of several other reports. StockNews.com initiated coverage on Ekso Bionics in a research note on Monday. They issued a “hold” rating on the stock. HC Wainwright reaffirmed a “buy” rating and issued a $9.00 price objective on shares of Ekso Bionics in a research note on Tuesday.

Ekso Bionics Price Performance

Shares of NASDAQ EKSO traded down $0.01 during midday trading on Tuesday, reaching $0.48. The company’s stock had a trading volume of 451,837 shares, compared to its average volume of 350,367. The company has a market cap of $10.48 million, a P/E ratio of -0.73 and a beta of 1.46. Ekso Bionics has a fifty-two week low of $0.40 and a fifty-two week high of $2.16. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.14 and a current ratio of 2.81. The business’s 50 day moving average price is $0.61 and its two-hundred day moving average price is $0.82.

Ekso Bionics (NASDAQ:EKSO) last posted its quarterly earnings data on Monday, March 3rd. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.07). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The firm had revenue of $5.09 million for the quarter, compared to the consensus estimate of $5.05 million. On average, analysts forecast that Ekso Bionics will post -0.48 EPS for the current fiscal year.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.